Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Feminizing hormone therapy increases kidney filtration rate.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

A female dog with mixed male and female traits was treated successfully with surgery.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Hair transplants can help transgender individuals match their appearance with their gender identity.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Antiandrogens block male hormones and are not safe during pregnancy.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.